Sevelamer prescriptions after reporting of the Dialysis Clinical Outcomes Revisited (DCOR) trial findings: An analysis of 5,495 patients receiving maintenance dialysis in Ontario, Canada.
Matthew A
MA
Weir
Arsh K
AK
Jain
Tara
T
Gomes
David N
DN
Juurlink
Muhammad
M
Mamdani
Lihua
L
Li
Amit X
AX
Garg
D000368:Aged; D000369:Aged, 80 and over; D002614:Chelating Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D054559:Hyperphosphatemia / Q000097:blood / Q000517:prevention & control*; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009864:Ontario; D011073:Polyamines / Q000627:therapeutic use*; D010818:Practice Patterns, Physicians'; D006435:Renal Dialysis; D000069603:Sevelamer
D002614:Chelating Agents; D011073:Polyamines; D000069603:Sevelamer